1. Home
  2. CELU vs CVGI Comparison

CELU vs CVGI Comparison

Compare CELU & CVGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • CVGI
  • Stock Information
  • Founded
  • CELU 2016
  • CVGI 2000
  • Country
  • CELU United States
  • CVGI United States
  • Employees
  • CELU N/A
  • CVGI N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • CVGI Auto Parts:O.E.M.
  • Sector
  • CELU Health Care
  • CVGI Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • CVGI Nasdaq
  • Market Cap
  • CELU 37.7M
  • CVGI 34.0M
  • IPO Year
  • CELU N/A
  • CVGI 2004
  • Fundamental
  • Price
  • CELU $2.29
  • CVGI $1.33
  • Analyst Decision
  • CELU
  • CVGI Buy
  • Analyst Count
  • CELU 0
  • CVGI 1
  • Target Price
  • CELU N/A
  • CVGI $10.00
  • AVG Volume (30 Days)
  • CELU 91.4K
  • CVGI 452.8K
  • Earning Date
  • CELU 05-08-2025
  • CVGI 05-06-2025
  • Dividend Yield
  • CELU N/A
  • CVGI N/A
  • EPS Growth
  • CELU N/A
  • CVGI N/A
  • EPS
  • CELU N/A
  • CVGI N/A
  • Revenue
  • CELU $54,220,000.00
  • CVGI $698,524,000.00
  • Revenue This Year
  • CELU $23.29
  • CVGI N/A
  • Revenue Next Year
  • CELU N/A
  • CVGI $6.12
  • P/E Ratio
  • CELU N/A
  • CVGI N/A
  • Revenue Growth
  • CELU 138.11
  • CVGI N/A
  • 52 Week Low
  • CELU $1.00
  • CVGI $0.81
  • 52 Week High
  • CELU $5.22
  • CVGI $5.69
  • Technical
  • Relative Strength Index (RSI)
  • CELU 62.18
  • CVGI 55.58
  • Support Level
  • CELU $1.90
  • CVGI $1.28
  • Resistance Level
  • CELU $2.11
  • CVGI $1.48
  • Average True Range (ATR)
  • CELU 0.28
  • CVGI 0.13
  • MACD
  • CELU 0.07
  • CVGI 0.02
  • Stochastic Oscillator
  • CELU 75.73
  • CVGI 72.58

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

Share on Social Networks: